Sign up with Facebook
- Health A to Z
- Healthy Living
Advertisement
News: February 14, 2012
Chemo During Pregnancy Doesn't Seem to Harm Baby
THURSDAY, Feb. 9 (HealthDay News) -- A new study finds that the babies of women who had chemotherapy while pregnant aren't at higher risk for a variety of medical disorders, a sign that the treatment should be safe for the fetus in most instances....
Fasting Plus Chemo May Help in Cancer Fight: Study
WEDNESDAY, Feb. 8 (HealthDay News) -- Fasting, especially when combined with chemotherapy, appears to slow the growth of cancerous tumors in mice, new research suggests. Experts note that the results of animal studies often don't hold up when trie...
DNA Damage From Chemo May Help Spur Leukemia's Return
THURSDAY, Jan. 12 (HealthDay News) -- The chemotherapy used to treat a form of adult leukemia sets a trap that can result in the return of the disease within years, a new study suggests. The finding confirms the suspicions of specialists who thoug...
Targeted Drugs, Lung CT Screening Top Cancer Advances in 2011
TUESDAY, Dec. 6 (HealthDay News) -- As the war against cancer continues, a group representing U.S. oncologists has picked its "Top Five" list of advances in cancer care for 2011. Leading the list are approvals for a bevy of new, targeted drugs for...
More Aggressive Chemo May Help Younger Lymphoma Patients: Study
THURSDAY, Nov. 24 (HealthDay News) -- Higher doses of chemotherapy with less time between treatments may benefit younger people suffering from aggressive lymphomas, such as diffuse large B-cell lymphoma (one of the most common and aggressive forms...
Drug Duo May Help Fight Aggressive Form of Breast Cancer
TUESDAY, Jan. 17 (HealthDay News) -- Combining two drugs that target an aggressive type of breast cancer known as HER2-positive appears to work better than using either drug alone, researchers report. The dual-drug approach greatly boosted the cha...
40 Years On, the Triumphs and Challenges of America's 'War on Cancer'
WEDNESDAY, Dec. 21 (HealthDay News) -- Jack Whelan first knew something was wrong when it got harder and harder to walk from the train station in Boston to the financial district where he worked. He knew something was terribly wrong when he starte...
Advances in Breast Cancer Care May Not Be Reaching Older Women
TUESDAY, Nov. 8 (HealthDay News) -- New research finds older U.S. women have higher odds of dying from breast cancer than younger women, suggesting that older patients may not be benefiting as much from advances in breast cancer care made over the...
Genetic Profiling Adds New Dimension to Breast Cancer Treatment
FRIDAY, Oct. 14 (HealthDay News) -- Treatment for breast cancer has advanced in recent years by becoming more and more personalized. Not personalized to the patient, mind you, but to the particular tumors and cancer cells inside that patient.
Woman Describes How Breast Cancer Changed Her Life
FRIDAY, Oct. 14 (HealthDay News) -- For Diana Rowden, life changed in various ways when she was diagnosed with breast cancer 20 years ago. During a routine gynecological exam when she was 38 years old, the doctor examining her breasts thought she ...
Elderly Lung Cancer Patients Can Gain From Two-Drug Chemo: Study
MONDAY, Aug. 8 (HealthDay News) -- Countering conventional wisdom, researchers in France say that elderly lung cancer patients can gain significant benefit from an aggressive, double-barreled chemotherapy that's often used in younger patients. The...
Tarceva Battles Lung Cancer in Some
THURSDAY, July 21 (HealthDay News) -- New research finds that the targeted cancer drug Tarceva nearly triples the amount of time lung cancer patients survive without a recurrence and has fewer side effects than standard chemotherapy. The authors o...
Experimental Drug Bests Chemo in Non-Small Cell Lung Cancer Study
TUESDAY, July 5 (HealthDay News) -- A drug designed to treat certain patients with non-small cell lung cancer boosts survival time without progression of cancer by several months, according to a new study. The findings reveal that the drug, known ...
Avastin Rejection Supported by Cancer Experts
FRIDAY, July 1 (HealthDay News) -- Oncologists and even some breast cancer support groups are endorsing a U.S. health advisory panel's recommendation that the blockbuster cancer drug Avastin be removed for use in metastatic breast cancer. The reas...
Taking Chemo Drug Continuously Delayed Lung Cancer's Return
SUNDAY, June 5 (HealthDay News) -- While most patients with advanced lung cancer only take four courses of two chemotherapy drugs and then stop until recurrence occurs, continuing treatment with one of those drugs may delay return of the deadly di...
After Colon Cancer Surgery, Early Chemo May Pay Off
SATURDAY, June 4 (HealthDay News) -- For patients undergoing surgery for colorectal cancer, a new study suggests that the sooner chemotherapy starts following the operation, the better the prognosis. For every month after the first four weeks post...
Cancer Drug Avastin Makes Inroads Against Ovarian Tumors
SATURDAY, June 4 (HealthDay News) -- Two new studies indicate that a common cancer drug, Avastin, may benefit both early stage ovarian cancer patients and women whose cancer has recurred. In both studies, presented Saturday at the annual meeting o...
New Drug Extends Survival for Men With Advanced Prostate Cancer
THURSDAY, May 26 (HealthDay News) -- For men with advanced hormone-resistant prostate cancer who have also failed chemotherapy, the new drug Zytiga (abiraterone acetate) along with the steroid prednisone appears to boost survival, researchers repo...
Childhood Cancer Therapies Tied to Gastrointestinal Issues
WEDNESDAY, May 25 (HealthDay News) -- Children who are successfully treated for cancer are at greater risk of developing mild to severe gastrointestinal problems down the road, a new study finds. Researchers from the University of California, San ...
New Drug Extends Life a Bit in Advanced Prostate Cancer
MONDAY, May 16 (HealthDay News) -- For men with advanced hormone-resistant prostate cancer who have also failed chemotherapy, the new drug Zytiga (abiraterone acetate) along with the steroid prednisone appears to increase survival modestly, a new ...
Nearly 20% of Lung Cancer Patients Keep Smoking
FRIDAY, April 8 (HealthDay News) -- Many patients diagnosed with lung cancer -- as well as their family caregivers -- continue to smoke even though doing so may jeopardize their recovery and long-term health outcome, says a study sponsored by the ...
Immune-Boost Treatment Might Help Some With Advanced Colon Cancer
WEDNESDAY, April 6 (HealthDay News) -- By giving more intensive chemotherapy along with drugs designed to boost the body's own immune system, researchers were able to roughly double survival time for patients with advanced, metastatic colorectal c...
Novel Treatment for Pancreatic Cancer Under Study
THURSDAY, March 24 (HealthDay News) -- Researchers appear to have found a new way to significantly shrink pancreatic tumors by targeting the tissue surrounding cancer rather than the cancer itself. The approach relies on an experimental antibody t...
Pot Ingredient May Restore Appetite After Chemo
WEDNESDAY, Feb. 23 (HealthDay News) -- The main active ingredient in marijuana seems to allow chemotherapy patients to regain their ability to taste and enjoy food, according to the results of a small new study. The finding could potentially lead ...
Stray Breast Tumor Cells in Early Chemo Could Be Bad Sign
FRIDAY, Dec. 10 (HealthDay News) -- High levels of breast cancer tumor cells circulating in the blood during the first round of chemotherapy are a sign that the patient may not do well in the long run. This was true even after other markers of sur...
Certain Drug Combinations May Beat Back Aggressive Breast Cancer
FRIDAY, Dec. 10 (HealthDay News) -- Combinations of targeted therapies for an especially aggressive type of breast cancer could potentially usher the majority of affected patients into remission, researchers at a major breast cancer meeting said F...
Blood Cancer Advances May Improve Survival
SATURDAY, Dec. 4 (HealthDay News) -- Advances in the treatment of blood cancers offer new hope for increased survival, according to two studies scheduled to be presented at the American Society of Hematology meeting Saturday in Orlando, Fla. Resul...
To Best Fight Cancer, New Guidelines Urge Exercise
FRIDAY, Nov. 5 (HealthDay News) -- People undergoing cancer treatment traditionally have been told to rest as much as possible and avoid exertion, to save all their strength to battle the dreaded disease. But a growing number of physicians and res...
Childhood Cancer Survivors Risk Future GI Problems
TUESDAY, Oct. 26 (HealthDay News) -- Children who survive cancer face an increased risk for gastrointestinal complications later on, a new study suggests. The findings highlight the increased need for long-term surveillance of GI problems among ch...
Insurance, Income Don't Explain 'Race Gap' in Breast Cancer Care
TUESDAY, Oct. 12 (HealthDay News) -- The so-called racial gap in breast cancer care has long been known by researchers, with black and Hispanic women less likely to get recommended breast cancer treatments than white patients. "Less well known is ...
New Clues to Treating Ovarian Cancer Relapse
THURSDAY, Sept. 30 (HealthDay News) -- New research finds that women with ovarian cancer relapse who start chemotherapy as soon as levels of a biomarker for the cancer rise don't live significantly longer than women who wait until symptoms begin t...
Experimental Leukemia Drug Proves a Slam Dunk
THURSDAY, Sept. 23 (HealthDay News) -- It was August 2004, and 24-year-old Ray Johnston was living his boyhood dream. He'd just been plucked from his life as a mortgage broker and plunked down on the courts of the National Basketball Association's...
Radiation for Childhood Cancer Can Boost Risk of Stillbirth Later
THURSDAY, July 22 (HealthDay News) -- Women who are childhood cancer survivors face a greater risk of having a stillborn child if their uterus or ovaries were exposed to radiation during their treatments, a new study finds. Although neither boys n...
Avastin Largely Safe for Patients With Type of Advanced Lung Cancer
TUESDAY, July 20 (HealthDay News) -- The cancer drug Avastin, when used in combination with standard chemotherapy, is safe and can effectively treat an advanced form of one of the most common lung cancers, researchers report. Previously it had bee...
Medicare Cuts May Have Led Docs to Prescribe More Chemo
THURSDAY, June 17 (HealthDay News) -- Cuts in Medicare payments to doctors who administer outpatient chemotherapy drugs actually led to an increase in treatment rates among Medicare recipients, finds a new study. "This sort of dynamic runs contrar...
Researchers Report Treatment Headway Against Lung Cancer
SATURDAY, June 5 (HealthDay News) -- Researchers report they prolonged survival for some patients with advanced non-small cell lung cancer, for whom the median survival is currently only about six months. One study discovered that an experimental ...
Studies Suggest New Treatment Paradigms for Ovarian, Prostate Cancers
SUNDAY, June 6 (HealthDay News) -- New research points toward novel ways to treat ovarian and prostate cancer, while producing a disappointment for those with a certain form of colon cancer. Both the ovarian and prostate cancer trials could change...
Making Your Way Through the Fog of Chemotherapy
FRIDAY, May 28 (HealthDay News) -- For many people with cancer, chemotherapy can be a lifeline to the future. And more aggressive, high-dose therapy has been shown to produce better results. But there's a downside, too: Chemotherapy is linked to a...
Post-Chemo Treatment May Boost Lung Cancer Survival
THURSDAY, May 20 (HealthDay News) -- Among people with non-small-cell lung cancer, treatment with the drug erlotinib (Tarceva) after chemotherapy appears to slightly boost survival rates, a new study suggests. Non-small-cell lung cancer makes up a...
Impotence Drugs May Aid Brain Tumor Treatment
WEDNESDAY, May 12 (HealthDay News) -- A drug already approved for the treatment of erectile dysfunction may actually help boost the effectiveness of treatments for brain tumors tied to both lung and breast cancer, research shows. The finding stems...
Bone-Strengthening Drug Guards Against Spread of Breast Cancer
WEDNESDAY, March 31 (HealthDay News) -- The bone-strengthening drug zoledronic acid (Zometa) reduces the spread of breast cancer by preventing chemotherapy-related bone loss, a new study suggests. Tumor cells released from the primary breast cance...
Protein in Breast Tumors May Predict Chemo Response
FRIDAY, March 26 (HealthDay News) --The presence of a substance in breast cancer tumors can help doctors predict how people will respond to chemotherapy, German researchers have found. "The relationship to total response was remarkable," Gunter vo...
Chemo Plus Synthetic Drug Shrunk Pancreatic Tumors
THURSDAY, March 25 (HealthDay News) -- When used with chemotherapy, an experimental synthetic drug called JP1201 was effective against human pancreatic cancer in mice, a new study found. JP1201 mimics that action of a naturally occurring protein (...
Chemo May Boost Survival After Lung Cancer Surgery
WEDNESDAY, March 24 (HealthDay News) -- Chemotherapy improves survival for patients with operable non-small cell lung cancer, say researchers who reviewed nearly 50 studies. The first meta-analysis of 34 studies involving almost 8,500 patients (an...
Older Colon Cancer Patients Less Likely to Get Chemo
TUESDAY, March 16 (HealthDay News) -- Older colon cancer patients are less likely than younger ones to receive potentially life-prolonging chemotherapy following surgery for their illness, a new study reveals. The research indicates that those wit...
Are New Chemo Treatments Cost-Effective?
TUESDAY, March 16 (HealthDay News) -- New chemotherapy agents for metastatic colon cancer improve patient survival but are costly, says a new study. Researchers at Emory University in Atlanta analyzed data from 4,665 patients, aged 66 and older, d...
Scientists Find Key to Hormone-Resistant Prostate Tumors
WEDNESDAY, March 10 (HealthDay News) -- Though hormone therapy has proven useful in treating late-stage prostate cancer, it often results in the development of fatal secondary tumors that are resistant to such therapy. Now, however, researchers wo...
Obese Colon Cancer Survivors Face Poorer Prognosis
TUESDAY, March 9 (HealthDay News) -- Colon cancer survivors who are moderately or severely obese face tougher survival odds following treatment compared with their normal-weight peers, a new study reveals. The finding builds on prior research that...
New Drugs, Approaches Offer Hope Against Prostate Cancer
WEDNESDAY, March 3 (HealthDay News) -- Scientists are making headway in finding ways to treat and detect stubborn forms of prostate cancer. The new hope comes from three studies being presented this week at the annual Genitourinary Cancers Symposi...
Rituxan Approved for Chronic Lymphocytic Leukemia
FRIDAY, Feb. 19 (HealthDay News) -- Rituxan (rituximab) has been approved by the U.S. Food and Drug Administration to treat a slowly progressing form of blood and bone marrow cancer known as chronic lymphocytic leukemia (CLL), the agency said in a...
Advertisement
